TY - JOUR T1 - Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: Results from the European postmarketing surveillance program JO - PEDIATRIC RESEARCH PY - 2008/08/01 AU - Beghetti M AU - Hoeper MM AU - Kiely DG AU - Carlsen J AU - Schwierin B AU - Segal ES AU - Humbert M ED - DO - DOI: 10.1203/PDR.0b013e318179954c VL - 64 IS - 2 SP - 200 EP - 204 Y2 - 2025/04/09 ER -